Latest Regulatory Milestones News

Ark Mines Limited has secured a crucial mining licence for its Sandy Mitchell Rare Earths Project in North Queensland, marking a key step toward development and commercialisation.

New Frontier Minerals has secured technical approval for its Mining Lease Application at the Big One Copper Deposit, setting the stage for potential near-term copper production amid a tightening global copper market.

Chariot Resources has raised $2.15 million in a well-supported placement to fund its acquisition and exploration of lithium assets in Nigeria, signalling strong investor confidence amid soaring lithium prices.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Cobram Estate Olives has secured US Department of Justice approval for its acquisition of California Olive Ranch, paving the way for completion by late March 2026.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.

Sky Metals reports significant new high-grade tin-tungsten-silver drilling results at its Tallebung Tin Project, confirming southern extensions and initiating the NSW State Significant Development approval process.

Condor Energy has updated its corporate presentation revealing significant progress in Peru’s Tumbes Basin, highlighting a 1 trillion cubic feet gas discovery and a multi-billion barrel oil exploration portfolio. The company is moving towards converting its evaluation agreement into a full exploration licence while advancing commercial discussions for gas offtake.

Chariot Resources has secured Nigerian government approval for the transfer of six lithium licenses, marking a key step toward acquiring a majority stake in a promising Nigerian lithium portfolio. This regulatory milestone enables immediate exploration and mining activities at multiple projects amid soaring lithium prices.

Dimerix Limited has completed dosing of the last adult patient in its ACTION3 Phase 3 trial for DMX-200, exceeding its recruitment target and setting the stage for key regulatory milestones.

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

South Harz Potash Limited has raised A$1.25 million to fund exploration at its newly licensed copper-gold projects in Sweden, signalling a strategic pivot towards critical minerals and a planned rebrand to Turnstone Resources.